↓ Skip to main content

Cochrane Database of Systematic Reviews

What is this page? Embed badge

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

Overview of attention for article published in Cochrane database of systematic reviews, March 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
9 tweeters
wikipedia
6 Wikipedia pages

Citations

dimensions_citation
348 Dimensions

Readers on

mendeley
527 Mendeley
Summary Twitter Wikipedia Dimensions citations
Title
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease
Published in
Cochrane database of systematic reviews, March 2012
DOI 10.1002/14651858.cd006504.pub2
Pubmed ID
22419314
Authors

Michal Rolinski, Chris Fox, Ian Maidment, Rupert McShane

Abstract

Previous Cochrane reviews have considered the use of cholinesterase inhibitors in both Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB). The clinical features of DLB and PDD have much in common and are distinguished primarily on the basis of whether or not parkinsonism precedes dementia by more than a year. Patients with both conditions have particularly severe deficits in cortical levels of the neurotransmitter acetylcholine. Therefore, blocking its breakdown using cholinesterase inhibitors may lead to clinical improvement.

View on publisher site

Twitter Demographics

The data shown below were collected from the profiles of 9 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 527 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 4 <1%
Switzerland 2 <1%
United States 2 <1%
Netherlands 1 <1%
Czechia 1 <1%
France 1 <1%
Germany 1 <1%
Belgium 1 <1%
Canada 1 <1%
Other 2 <1%
Unknown 511 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 80 15%
Researcher 67 13%
Student > Ph. D. Student 61 12%
Student > Master 61 12%
Student > Postgraduate 44 8%
Other 119 23%
Unknown 95 18%
Readers by discipline Count As %
Medicine and Dentistry 191 36%
Psychology 48 9%
Neuroscience 45 9%
Agricultural and Biological Sciences 22 4%
Nursing and Health Professions 22 4%
Other 72 14%
Unknown 127 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2019.
All research outputs
#4,046,622
of 23,206,358 outputs
Outputs from Cochrane database of systematic reviews
#6,511
of 12,392 outputs
Outputs of similar age
#26,152
of 157,678 outputs
Outputs of similar age from Cochrane database of systematic reviews
#84
of 182 outputs
Altmetric has tracked 23,206,358 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,392 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.6. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 157,678 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 182 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.

This page is hosted by Altmetric on behalf of Cochrane Library.